Endocrinology, Vol 126, 88-94, Copyright © 1990 by Endocrine Society

ARTICLES

Prolactin induction of interleukin-2 receptors on rat splenic lymphocytes

P Mukherjee, AM Mastro and WC Hymer
Department of Molecular and Cell Biology, Penn State University, University Park 16802.

A case for the involvement of PRL in the regulation of the immune system is strong. However, no mechanism by which PRL exerts this regulation has yet been identified. We studied the in vitro effects of PRL on splenocytes from ovariectomized (OVX) rats and discovered that PRL induced the formation of interleukin-2 (IL-2) cell surface receptors. However, PRL did not induce IL-2 secretion. This response, which was dependent on the concentration of PRL, also depended upon the estrogen status of the splenocyte donor; thus, splenocytes from OVX rats or rats in diestrus responded to PRL, whereas those from estrogen- treated OVX rats or rats in estrus did not. We propose that in vivo exposure of PRL, under certain physiological conditions, may prime a pool of splenocytes to express IL-2 cell surface receptors, allowing these cells to be responsive to variations in local concentrations of IL-2.

This article has been cited by other articles:

				J. Cote-Sierra, G. Foucras, L. Guo, L. Chiodetti, H. A. Young, J. Hu-Li, J. Zhu, and W. E. Paul Interleukin 2 plays a central role in Th2 differentiation PNAS, March 16, 2004; 101(11): 3880 - 3885. [Abstract] [Full Text] [PDF]

				L Daza, C Lavalle, C Duarte, R Huerta, and J Moreno Lack of association between hyperprolactinemia and soluble IL-2 receptor levels in systemic lupus erythematosus Lupus, February 1, 2003; 12(2): 107 - 111. [Abstract] [PDF]

				R. H. Straub, J. Georgi, K. Helmke, P. Vaith, and B. Lang In polymyalgia rheumatica serum prolactin is positively correlated with the number of typical symptoms but not with typical inflammatory markers Rheumatology, April 1, 2002; 41(4): 423 - 429. [Abstract] [Full Text] [PDF]

				L Matera, M Mori, and A Galetto Effect of prolactin on the antigen presenting function of monocyte-derived dendritic cells Lupus, October 1, 2001; 10(10): 728 - 734. [Abstract] [PDF]

				S E Walker Bromocriptine treatment of systemic lupus erythematosus Lupus, October 1, 2001; 10(10): 762 - 768. [Abstract] [PDF]

				A. J. Pool and J. S. Axford The effects of exercise on the hormonal and immune systems in rheumatoid arthritis Rheumatology, June 1, 2001; 40(6): 610 - 614. [Full Text] [PDF]

				S E Walker Treatment of systemic lupus erythematosus with bromocriptine Lupus, March 1, 2001; 10(3): 197 - 202. [Abstract] [PDF]

				A M Jacobi, W Rohde, H-D Volk, T Dorner, G-R Burmester, and F Hiepe Prolactin enhances the in vitro production of IgG in peripheral blood mononuclear cells from patients with systemic lupus erythematosus but not from healthy controls Ann Rheum Dis, March 1, 2001; 60(3): 242 - 247. [Abstract] [Full Text] [PDF]

				W. Savino and M. Dardenne Neuroendocrine Control of Thymus Physiology Endocr. Rev., August 1, 2000; 21(4): 412 - 443. [Abstract] [Full Text] [PDF]

				M. W. Knoferl, M. K. Angele, A. Ayala, W. G. Cioffi, K. I. Bland, and I. H. Chaudry Insight into the mechanism by which metoclopramide improves immune functions after trauma-hemorrhage Am J Physiol Cell Physiol, July 1, 2000; 279(1): C72 - C80. [Abstract] [Full Text] [PDF]

				K. Dorshkind and N. D. Horseman The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency Endocr. Rev., June 1, 2000; 21(3): 292 - 312. [Abstract] [Full Text]

				P. Morales, M. V. Carretero, H. Geronimo, S. G. Copín, M. L. Gaspar, M. A. R. Marcos, and J. Martín-Pérez Influence of Prolactin on the Differentiation of Mouse B-Lymphoid Precursors Cell Growth Differ., August 1, 1999; 10(8): 583 - 590. [Abstract] [Full Text]

				B. Bouchard, C. J. Ormandy, J. P. Di Santo, and P. A. Kelly Immune System Development and Function in Prolactin Receptor-Deficient Mice J. Immunol., July 15, 1999; 163(2): 576 - 582. [Abstract] [Full Text] [PDF]

				C. P. Castro, R. Peñalva, M. P. Pereda, U. Renner, J. M. H. M. Reul, G. K. Stalla, F. Holsboer, and E. Arzt Early Activation of Thyrotropin-Releasing-Hormone and Prolactin Plays a Critical Role during a T Cell-Dependent Immune Response Endocrinology, February 1, 1999; 140(2): 690 - 697. [Abstract] [Full Text]

				M A Gutierrez, M E Garcia, J A Rodriguez, S Rivero, and S Jacobelli Hypothalamic-pituitary-adrenal axis function and prolactin secretion in systemic lupus erythematosus Lupus, July 1, 1998; 7(6): 404 - 408. [Abstract] [PDF]

				C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]

				M. Gutierrez, J. Molina, L. Jara, M. Cuellar, C. Garcia, S. Gutierrez-Urena, A. Gharavi, and L. Espinoza Prolactin and systemic lupus erythematosus: prolactin secretion by SLE lymphocytes and proliferative (autocrine) activity Lupus, October 1, 1995; 4(5): 348 - 352. [Abstract] [PDF]

				C. V. Clevenger, W. Ngo, D. L. Sokol, S. M. Luger, and , A. M. Gewirtz Vav Is Necessary for Prolactin-stimulated Proliferation and Is Translocated into the Nucleus of a T-cell Line J. Biol. Chem., June 2, 1995; 270(22): 13246 - 13253. [Abstract] [Full Text] [PDF]